Home › IncellDx Signs Agreement With Bristol-Myers Squibb Related To The Development Of An Assay For A Companion Diagnostic Test
 

Keywords :   


IncellDx Signs Agreement With Bristol-Myers Squibb Related To The Development Of An Assay For A Companion Diagnostic Test

2013-10-30 05:49:33| drugdiscoveryonline News Articles

IncellDx, Inc. announced today that they have entered into an agreement with Bristol-Myers Squibb Company (NYSE:BMY) related to the development of an assay for potential application in a molecular companion diagnostic intended to identify patients likely to benefit from treatment with a Bristol-Myers Squibb drug that is currently under development

Tags: related development test agreement

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11PlayStationVitaPCH-2000
23.11GB
23.11 Malbon
23.11PING PEARL GATES
23.11WATCH
23.11L
23.11Tetsuya_SP2 DMC
23.116
More »